| Name | Abingdon Health |
|---|---|
| Epic | ABDX |
| Isin | GB00BLF79J41 |
| Industry | Medical Equipment and Services |
| Latest share price | 9.30p | Net gearing | n/a |
|---|---|---|---|
| Market capitalisation | £18.01 | Debt ratio | n/a |
| Shares in issue | 126.72 | Debt-to-equity ratio | n/a |
| P/E ratio | n/a | Assets / equity ratio | n/a |
| Total dividends per share | n/a | Price to book value | n/a |
| Dividend yield | n/a | ROCE | -90.73 |
| Dividend cover | n/a | EPS growth | n/a |
| Earning per share | -1.14 | 52-week high / low | 6.75p / 13.00p |
| Type | Ex-date | Pay-date | Net-dividend |
|---|---|---|---|
| No dividends declared | |||
| Company name | Abingdon Health |
|---|---|
| Address | York Biotech Campus, Sand Hutton, York, England, United Kingdom, YO41 1LZ |
| Telephone | +44 (0)1904 406082 |
| Website | http://www.abingdonhealth.com/ |
| Director | Position |
|---|---|
| Mr Chris Henry Francis Yates | CEO |
| Dr Christopher Hand | Non-Executive Chairman |
| Ms Mary G Tavener | Independent Non-Executive Director |
| Assets £ (m) | 2023 | 2022 | 2021 |
|---|---|---|---|
| Reporting date | 30/06/23 | 30/06/22 | 30/06/21 |
| Intangible asssets and goodwill | 0.09 | 0.04 | 1.23 |
| Investments and other non-current assets | n/a | n/a | n/a |
| Total non-current assets | 1.3 | 1.81 | 10.27 |
| Inventory / work in progress | 0.33 | 0.53 | 7.89 |
| Trade and other receivables | 1.2 | 8.03 | 10.09 |
| Cash and equivalents | 3.24 | 2.4 | 4.98 |
| Other current assets and asset held for resale | n/a | n/a | n/a |
| Total of all assets | 6.06 | 12.77 | 33.23 |
| Liabilities £ (m) | 2023 | 2022 | 2021 |
|---|---|---|---|
| Short term liabilities | 2.12 | 5.32 | 10.76 |
| Long term liabilities | 0.93 | 1.01 | 1.14 |
| Other liabilites / pension etc | n/a | n/a | n/a |
| Total of all liabilities | 3.05 | 6.34 | 11.9 |
| Net assets £ (m) | 2023 | 2022 | 2021 |
|---|---|---|---|
| Net assets | 3.01 | 6.43 | 21.33 |
| Equity £ (m) | 2023 | 2022 | 2021 |
|---|---|---|---|
| Share capital | 0.08 | 0.08 | 0.07 |
| Minority interests | n/a | n/a | n/a |
| Retained earnings | -27.46 | -24.11 | -2.97 |
| Share premium account | 30.31 | 30.31 | 24.18 |
| Total equity | 3.01 | 6.43 | 21.33 |
| Income £ (m) | 2023 | 2022 | 2021 |
|---|---|---|---|
| Turnover | n/a | n/a | n/a |
| Operating profit | -3.57 | -21.53 | -6.72 |
| Pre-tax profit | -3.56 | -21.59 | -6.95 |